Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.7B | 3.1B | 2.9B | 3.1B |
Cost of revenue | 1.9B | 2.2B | 2.0B | 2.2B |
Gross profit | 837M | 941M | 873M | 941M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 773M | 903M | 834M | 854M |
Other operating expenses | 107M | 120M | 112M | 121M |
Operating income | -43M | -82M | -73M | -34M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 23M | 14M | 5M | 4M |
Other income expense | -44M | -30M | 7M | -2M |
Pretax income | -110M | -126M | -71M | -40M |
Tax provision | 3M | 2M | 3M | 2M |
Net income | -113M | -128M | -74M | -42M |
Basic EPS | -0.9 | -1.0 | -0.6 | -0.3 |
Diluted EPS | -0.9 | -1.0 | -0.6 | -0.3 |
Basic average shares | 127M | 125M | 123M | 122M |
Diluted average shares | 127M | 125M | 123M | 122M |
EBITDA | 48M | 5M | 29M | 64M |
Net income from continuing op. | -113M | -128M | -74M | -42M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |